Evaluation of Naltrexone as a Treatment for Self-injurious Behavior

NCT02726035 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI deceased

Conditions

Self-injurious Behavior
Self Mutilation

Interventions

DRUG: Naltrexone
OTHER: Placebo

Sponsor

Western Michigan University School of Medicine

Collaborators

[object Object]